U.S. stocks finished the week slightly lower as investors gave today s poor housing data a slack, and blame it on the weather. “Investors are willing to cut the market some slack because of the weather; I m keeping my fingers crossed that the economy heats up as the weather warms up,” Jack. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to:
In a report published Wednesday, Leerink analyst Paul Matteis commented on Orexigen Therapeutics, Inc. (NASDAQ: OREX) and wrote that following a positive opinion from the CHMP, the company expects a final opinion from the EMA on the Mysimba (Contrave) marketing authorization application.
Matteis. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to: